From October 1, 2022 to December 9, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 42,941 shares, representing 0.29% for KRW 1,521.88 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,880 KRW | -0.94% | -1.63% | -1.29% |
1st Jan change | Capi. | |
---|---|---|
-1.29% | 180M | |
+20.08% | 22.46B | |
+17.78% | 15.04B | |
+18.94% | 13.98B | |
+56.80% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.03% | 5.71B | |
+6.11% | 4.69B |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.